PACIRA PHARMACEUTICALS INC

NASDAQ: PCRX
$60.77
+$0.88 (+1.5%)
Closing price September 18, 2020
Friday's top analyst upgrades, downgrades and initiations Apple, Centene, Comcast, Electronic Arts, Facebook, Intel, PG&E, Procter & Gamble, SLM, Take-Two Interactive Software and Travelers.
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm and Sirius XM.
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) has found itself in the middle of a great opportunity but not being able to make the last mile of the race. Unfortunately, pain management in a non-opioid...
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial and FDA updates in April.
The top analyst upgrades, downgrades and other research calls from Wednesday include Allergan, Autodesk, Home Depot, Marvell, Qualcomm, UnitedHealth and Walmart.
The top analyst upgrades, downgrades and other research calls from Thursday include Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile and Wix.com.
The top analyst upgrades, downgrades and other research calls from Thursday include Barrick Gold, Buffalo Wild Wings, Caterpillar, Coca-Cola, GrubHub, Nabors Industries and Wynn Resorts.
Stocks were indicated to open marginally lower on Monday ahead of the Great American Eclipse, but investors need to keep in mind that the markets are still very close to all-time highs. The one trend...
The top analyst upgrades, downgrades and initiations seen on Thursday include Adobe, ClubCorp, Oracle, Silver Wheaton, Weatherford International and Yahoo.
In this week's top stock picks from Jefferies, three very prominent biotechnology stocks are featured, including one that is a large cap leader.
Here are three biotech companies that not only have data that could prove to be huge, but their shares have been absolutely hammered over the last year, offering aggressive accounts the best entry...
Thursday’s top analyst upgrades, downgrades and initiations include Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC and Pure Storage.
These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.